Revenue Performance
CME Group achieved Q4 2024 revenue of $1.525 billion. This reflects a downturn in quarterly performance (down 3.73% from Q3), but a strong year-on-year growth of 5.98%, signalling continuity in demand for CME's diversified financial products.
Profitability Metrics
The company reported a gross profit ratio of 85.52%, indicating efficient cost management amidst increasing operational expenses. The operating income of $947.1 million resulted in an operating income ratio of 62.09%, underscoring strong operational efficiency. Net income rose to $874.6 million with a net income margin of 57.34%. Compared to Q3, operating income saw a decrease of 7.53%, partially due to rising costs in other expenses.
Balance Sheet Health
CME maintains a strong financial position with total assets worth $137.45 billion and total liabilities of $110.96 billion, indicating a robust equity base of $26.49 billion. Significant cash holdings amounting to $2.89 billion demonstrate liquidity and financial stability.
Cash Flow Insights
The cash flow from operations was strong at $1.018 billion, with free cash flow also demonstrating strength at $991.7 million, suggesting healthy cash generation capabilities.